ETNB - Financial Reports List - 89bio, Inc. - IntrinsicAlpha

89bio, Inc. ETNB

Healthcare - Biotechnology - NASDAQ - US

$ 6.55

3.47 %

$ 956 M

Market Cap

-1.79

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-194.16%	-196.09%
Annual Report	FY	10-K	2024-12-31	0.00%	-158.16%	-154.40%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-329.30%	-286.17%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-24.95%	-26.84%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	38.56%	-200.80%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-63.54%	-162.47%
Annual Report	FY	10-K	2023-12-31	0.00%	-39.37%	-147.88%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-29.55%	-45.50%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-51.33%	-70.30%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-229.05%	213.61%

1